does microdosing glp 1 cause side effects Ozempic: Benefits, risks and what doctors say People Are Microdosing Weight-Loss Drugs

Aronson, G

The higher-dose semaglutide formulation for obesity (Wegovy, 2.4 mg weekly) can produce 10-15% weight loss, while diabetes doses typically yield more modest reductions

The need to consider switching or starting alternative therapies may have a significant impact on workload for primary care and community and specialist diabetes teams, and may cause people with diabetes anxiety and concern

Refund protection: Narrow - refunds only for medical disqualification or billing error

We will never sell your information, for any reason.

Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial